We now have to change the way we classify, diagnose and treat neuropathic pain from an etiology-based to a mechanism-based approach. In clinical practice, the diagnostic work-up should aim at ...

Neuropathic pain syndrome is a challenge to treat and ... including a fundamental mechanism-based approach, a clinical mechanism-based approach and an evidence-based approach.

Neuropathic pain syndromes remain a major therapeutic ... If these possibilities are correct, we could develop a new generation of mechanism-based drugs that can mute the roar of pain effectively.

This unique mechanism is believed to contribute to ... has granted Fast Track designation to AV-101 for the treatment of ...

Neuropathic pain can occur after severe injuries and ... Algiax's candidate offers a new potential mechanism of action for pain relief, and is thought to work by correcting excessive activation ...

Vertex is also exploring the potential of suzetrigine in treating peripheral neuropathic pain ... The therapy’s mechanism ...

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a clinical-stage pharmaceutical company developing breakthrough therapeutics for neurologic and neuropsychiatric disorders, today announced the enrollment of ...